These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9327896)

  • 1. Imaging of monoaminergic and cholinergic vesicular transporters in the brain.
    Frey KA; Wieland DM; Kilbourn MR
    Adv Pharmacol; 1998; 42():269-72. PubMed ID: 9327896
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional identification of vesicular monoamine and acetylcholine transporters.
    Varoqui H; Erickson JD
    Methods Enzymol; 1998; 296():84-99. PubMed ID: 9779442
    [No Abstract]   [Full Text] [Related]  

  • 3. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system.
    Schäfer MK; Eiden LE; Weihe E
    Neuroscience; 1998 May; 84(2):331-59. PubMed ID: 9539209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
    Kilbourn MR; DaSilva JN; Frey KA; Koeppe RA; Kuhl DE
    J Neurochem; 1993 Jun; 60(6):2315-8. PubMed ID: 8492135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Caenorhabditis elegans to study vesicular transport.
    Rand JB; Duerr JS; Frisby DL
    Methods Enzymol; 1998; 296():529-47. PubMed ID: 9779472
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of neurotransmitter transport into secretory vesicles.
    Finn JP; Merickel A; Edwards RH
    Methods Enzymol; 1998; 296():144-62. PubMed ID: 9779446
    [No Abstract]   [Full Text] [Related]  

  • 8. Identified neurons in C. elegans coexpress vesicular transporters for acetylcholine and monoamines.
    Duerr JS; Gaskin J; Rand JB
    Am J Physiol Cell Physiol; 2001 Jun; 280(6):C1616-22. PubMed ID: 11350757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vesicular monoamine transporter VMAT2 and vesicular acetylcholine transporter VAChT are sorted to separate vesicle populations in PC12 cells.
    Tao-Cheng JH; Eiden LE
    Adv Pharmacol; 1998; 42():250-3. PubMed ID: 9327891
    [No Abstract]   [Full Text] [Related]  

  • 10. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.
    Gilman S; Chervin RD; Koeppe RA; Consens FB; Little R; An H; Junck L; Heumann M
    Neurology; 2003 Jul; 61(1):35-9. PubMed ID: 12847153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo imaging of the vesicular acetylcholine transporter and the vesicular monoamine transporter.
    Efange SM
    FASEB J; 2000 Dec; 14(15):2401-13. PubMed ID: 11099458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
    Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIP and NPY expression during differentiation of cholinergic and noradrenergic sympathetic neurons.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Ann N Y Acad Sci; 1998 Dec; 865():537-41. PubMed ID: 9928065
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic vesicular transporters in progressive supranuclear palsy.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Neurology; 2002 Apr; 58(7):1013-8. PubMed ID: 11940684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.
    Kilbourn M; Frey K
    Eur J Pharmacol; 1996 Jun; 307(2):227-32. PubMed ID: 8832225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
    Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic, monoaminergic and glutamatergic changes following perinatal asphyxia in the rat.
    Kohlhauser C; Mosgoeller W; Hoeger H; Lubec G; Lubec B
    Cell Mol Life Sci; 1999 Aug; 55(11):1491-501. PubMed ID: 10518995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.